Insider trading

Period: 12 months Stock: OLMA Role: Other officers × + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

11 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

11 decisions over 12 months Remove this filter
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

11 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

11 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
11 decisions over 12 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
11 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

11 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
4 Mar 2026
Mitchell Shawnte CHIEF LEGAL OFFICER
Sold at will 2×
$606.35K 25,000 at 24.25
100%
Sold half or more
3 Mar 2026
Mitchell Shawnte CHIEF LEGAL OFFICER
Sold at will
$345.15K 15,000 at 23.01
100%
Sold half or more
15 Jan 2026
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Sold at will
$2.87M 100,000 at 28.73
41.7%
Not planned
14 Jan 2026
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will 2×
$1.44M 50,000 at 28.87
8.4%
Not planned
13 Jan 2026
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will 2×
$1.38M 50,000 at 27.60
8.4%
Not planned
13 Jan 2026
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF.
Sold at will
$107.05K 3,822 at 28.01
1.6%
Not planned
12 Jan 2026
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF · indirect
Sold at will
$283.40K 10,000 at 28.34
6.5%
Not planned
23 Dec 2025
Zojwalla Naseem Chief Medical Officer
Sold at will
$2.75M 99,509 at 27.66
95.7%
Sold half or more
22 Dec 2025
Zojwalla Naseem Chief Medical Officer
Sold at will
$2.80M 100,000 at 28.04
64.9%
Sold half or more
19 Dec 2025
Zojwalla Naseem Chief Medical Officer
Sold at will 2×
$1.97M 70,000 at 28.20
40.2%
Not planned
19 Dec 2025
Myles David C. CH. DISCOV. & NON-CLIN DEV OFF
Sold at will 3×
$1.55M 51,000 at 30.46
8.5%
Not planned
Showing 1–11 of 11.